Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artrya Limited ( (AU:AYA) ) has issued an update.
Artrya Limited has announced the quotation of 774,901 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AYA, effective September 19, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional liquidity for its stakeholders, potentially strengthening its position in the medical technology sector.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the medical technology industry, focusing on developing innovative solutions for the diagnosis and management of coronary artery disease. The company leverages advanced imaging and artificial intelligence to enhance cardiovascular health outcomes.
Average Trading Volume: 593,852
Technical Sentiment Signal: Buy
Current Market Cap: A$338.2M
See more insights into AYA stock on TipRanks’ Stock Analysis page.